Fred Hutch Cancer Center researchers are seeking better ways to prevent, detect and treat bladder cancer. We are also working to better understand the factors that affect each person’s risk for this cancer. Our scientists are also developing new methods to gauge how well a tumor will respond to treatment.
Physician-researchers at Fred Hutch are running many clinical trials of new drugs and drug combinations to treat different types of bladder cancer. These experimental therapies are part of a trend toward precision cancer care. The idea behind precision care is to target a patient’s tumor based on its molecular profile. We continue to hunt for more potential targets on bladder cancer cells that could lead to even more treatment options.
Bladder Cancer Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Researchers ID Potential New Drug Target in Bladder Cancer
Andrew Hsieh, MD, and Sujata Jana, PhD, former postdoctoral research fellow and now staff scientist, found that blocking protein synthesis slows bladder tumor development and progression in lab studies.
Our Bladder Cancer Researchers and Faculty
Our scientists and providers work together to prevent, diagnose and treat bladder cancer as well as other cancers and diseases. The lab research and clinical research they do are essential parts of the scientific process that leads to new treatments and better care. Many of our bladder cancer providers also do research in addition to seeing patients. Clinical trials can also be a way for patients to get early access to new leading-edge therapies. Our research teams are running many clinical studies for people with bladder cancer.
Steven M. Blinka, MD, PhD
Steven M. Blinka, MD, PhD
Assistant Professor, Clinical Research Division, Fred Hutch
1 more appointment
Heather H. Cheng, MD, PhD
Heather H. Cheng, MD, PhD
Professor, Clinical Research Division, Fred Hutch
Clinical Director, Cancer Genetics, Fred Hutch
1 more appointment
Lawrence Fong, MD
Lawrence Fong, MD
Scientific Director, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Professor, Translational Science and Therapeutics Division, Fred Hutch
5 more appointments
Lab Website
Andrew Hsieh, MD
Andrew Hsieh, MD
Professor and Associate Director, Human Biology Division, Fred Hutch
Professor, Clinical Research Division, Fred Hutch
3 more appointments
Lab Website
Hiba Khan, MD, MPH
Hiba Khan, MD, MPH
Assistant Professor, Clinical Research Division, Fred Hutch
Member, Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch
1 more appointment
Sylvia Lee, MD
Sylvia Lee, MD
Associate Professor, Program in Immunology, Clinical Research Division, Fred Hutch
Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
1 more appointment
Daniel Lin, MD
Daniel Lin, MD
Professor, Cancer Prevention Program, Public Health Sciences Division, Fred Hutch
5 more appointments
Omar Mian, MD, PhD
Omar Mian, MD, PhD
Associate Professor, Human Biology Division, Fred Hutch
Associate Professor, Precision Radiation Sciences Lead, Radiation Oncology Division, Fred Hutch
1 more appointment
Lab Website
Rosa Nadal Rios, MD, PhD
Rosa Nadal Rios, MD, PhD
Associate Professor, Clinical Research Division, Fred Hutch
Ruben Raychaudhuri, MD
Ruben Raychaudhuri, MD
Assistant Professor, Clinical Research Division, Fred Hutch
Michael Schweizer, MD
Michael Schweizer, MD
Professor, Clinical Research Division, Fred Hutch
Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
2 more appointments
Jonathan L. Wright, MD, MS, FACS
Jonathan L. Wright, MD, MS, FACS
Associate Professor, Public Health Sciences Division, Fred Hutch
5 more appointments
Evan Ya-Wen Yu, MD
Evan Ya-Wen Yu, MD
Section Head, Medical Oncology, Clinical Research Division, Fred Hutch
Professor, Clinical Research Division, Fred Hutch
3 more appointments